AORT (Artivion) GF Score : 81/100 (As of Mar. 28, 2025)

View and export this data going back to 1993. Start your Free Trial

What is Artivion GF Score?

Artivion has the GF Score of 81, which implies that the company might have Good outperformance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 4/10
2. Profitability Rank : 5/10
3. Growth Rank : 9/10
4. GF Value Rank : 5/10
5. Momentum Rank : 10/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Artivion might have Good outperformance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Artivion's GF Score

For the Medical Devices subindustry, Artivion's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Artivion's GF Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Artivion's GF Score distribution charts can be found below:

* The bar in red indicates where Artivion's GF Score falls into.

Save Embed

;

Save Embed

;

Artivion (NYSE:AORT) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Artivion GF Score Related Terms

Thank you for viewing the detailed overview of Artivion's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Artivion Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Artivion Inc (NYSE:AORT) » Definitions » GF Score

Comparable Companies

Traded in Other Exchanges

CYL:Germany CYL:Germany

Address

1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144

Website

https://www.artivion.com

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Executives

Jean F Holloway	officer: VP, General Counsel	C/O ARTIVION INC, 1655 ROBERTS BLVD, KENNESAW GA 30144
John E Davis	officer: Senior VP, Global Sales	1655 ROBERTS BLVD., NW, KENNESAW GA 30144
Marshall S. Stanton	officer: SVP, Clinical & MD Affair	1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Amy Horton	officer: Chief Accounting Officer	C/O CRYOLIFE, INC., 1655 ROBERTS BLVD., NW, KENNESAW GA 30144
James P Mackin	officer: President & CEO	ARTIVION, INC., 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Anthony B. Semedo	director	3288 HARRISON GRADE ROAD, SEBASTOPOL CA 95472
Andrew M Green	officer: VP Regulatory	ARTIVION INC, 1655 ROBERTS BLVD, KENNESAW GA 30144
Matthew A Getz	officer: VP, Human Resources	1655 ROBERTS BLVD NW, KENNESAW GA 30144
Rochelle L. Maney	officer: VP, Quality	1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Florian Tyrs	officer: VP, Global Operations	IM SOELLER 3, BALINGEN 2M 72336
Robert C Thomson	officer: VP Research & Development	33 HABERSHAM COVE DRIVE, NW, ATLANTA GA 30305
Dennis B Maier	officer: Vice President, Operations	1655 ROBERTS BLVD, NW, KENNESAW GA 30144
David Ashley Lee	officer: Executive VP, COO & CFO	C/O CRYOLIFE INC, 1655 ROBERTS BLVD NW, KENNESAW GA 30144
Elizabeth A Hoff	director	2701 WESTHEIMER ROAD, UNIT 1-E, HOUSTON TX 77098
Ronald D Mccall	director	C/O CRYOLIFE, INC., 1655 ROBERTS BOULEVARD, NW, KENNESAW GA 30144